Abstract

Previous studies addressing functional aspects of nuclear factor kappaB (NF-kappaB) activation in normal and transformed keratinocytes revealed complex and seemingly contradictory roles of this transcription factor in this cell type. In normal skin, NF-kappaB signaling seems to inhibit squamous cell carcinoma development whereas, in squamous cell carcinoma themselves, deregulated NF-kappaB expression and/or signaling is frequently observed. To further investigate this paradox, we focused on NF-kappaB activation as it relates to the transformed phenotype of immortalized but nontumorigenic human keratinocytes (HaCaT cells). We observed that NF-kappaB activity contributed to survival and growth of cultured HaCaT keratinocytes as shown by use of pharmacologic NF-kappaB inhibitors, RNA interference, and inducible overexpression of a dominant interfering IkappaB construct. NF-kappaB activation was largely provided through interaction with extracellular matrix components because preventing cell attachment by forced suspension culture markedly reduced NFkappaB signaling associated with cell death (anoikis); conversely, anoikis was partially reversed by NF-kappaB activation induced either by tumor necrosis factor-alpha treatment or by overexpressing the NF-kappaB p65 subunit in HaCaT cells. Furthermore, overexpression of NF-kappaBp65 in HaCaT cells induced colony formation in soft agar and tumorigenicity in nude mice. In summary, as opposed to normal keratinocytes, immortalized HaCaT keratinocytes provide a cellular context in which deregulated NF-kappaB signaling supports multiple malignant traits in vitro and in vivo.

Highlights

  • The transcription factor nuclear factor nB (NF-nB) was first identified as a nuclear factor in B lymphocytes, which binds to the enhancer of the immunoglobulin n light chain

  • This study presents multiple lines of evidence in support of oncogenic properties of NF-nB in an epidermal cell line representing an early stage of squamous cell carcinoma development

  • The results presented here assign a role to TNF-a-induced NF-nB signaling in survival of HaCaT cells, in the anchorage-independent state

Read more

Summary

Introduction

The transcription factor nuclear factor nB (NF-nB) was first identified as a nuclear factor in B lymphocytes, which binds to the enhancer of the immunoglobulin n light chain. The NF-nB family contains several members including Rel A (p65), Rel B, c-Rel, p50 (NF-nB1), and p52 (NF-nB2), which exist as homodimers and heterodimers retained by ankyrin domain–containing InBs in the cytoplasm of unstimulated cells Note: Supplementary data for this article are available at Cancer Research Online (http://cancerres.aacrjournals.org/). Dissociation from InB enables nuclear translocation of NF-nB dimers where they direct transcription of a host of target genes, many of which encode antiapoptotic proteins. In addition to their roles in immune and inflammatory processes, NF-nB family members have been observed to have oncogenic properties [2]. Consistent with important roles of NF-nB in tumorigenesis, enhanced NF-nB activity has been observed in malignant tumors of diverse origin including carcinomas ( for review, see ref. 3)

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call